Page last updated: 2024-09-05

atropine and Prostatic Neoplasms

atropine has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernards, C; Corman, JM; Holman, M; Kozlowski, P; Lukasewycz, S; Neil, N; Odom, E; Porter, CR1
Avancès, C; Culine, S; El Demery, M; Iborra, F; Lamy, PJ; Pinguet, F1

Trials

2 trial(s) available for atropine and Prostatic Neoplasms

ArticleYear
Does a perioperative belladonna and opium suppository improve postoperative pain following robotic assisted laparoscopic radical prostatectomy? Results of a single institution randomized study.
    The Canadian journal of urology, 2010, Volume: 17, Issue:5

    Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Atropa belladonna; Atropine; Double-Blind Method; Humans; Laparoscopy; Male; Middle Aged; Morphine; Muscarinic Antagonists; Pain, Postoperative; Phytotherapy; Plant Preparations; Preoperative Care; Prostatectomy; Prostatic Neoplasms; Robotics; Scopolamine; Suppositories

2010
Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers.
    The Journal of urology, 2007, Volume: 178, Issue:3 Pt 1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Atropine; Biomarkers, Tumor; Chromogranin A; Cisplatin; Docetaxel; Humans; Male; Phosphopyruvate Hydratase; Prostatic Neoplasms; Taxoids

2007